abstract |
Provided are a compound, which has a structure of formula (I) and is capable of inhibiting HPK1 kinase activity, and a pharmaceutical composition comprising the compound. Further provided is the use of the compound in the prevention and/or treatment of cancers, tumors, inflammatory diseases, autoimmune diseases or immune-mediated diseases. |